Abstract:AimSerum- and glucocorticoid-inducible kinase SGK1 functions as an important regulator of transepithelial sodium transport by activating epithelial sodium channel in renal tubules. Considerable evidence demonstrated that SGK1 was associated with hypertension and fibrosing diseases, such as diabetic nephropathy and glomerulonephritis. The present study was performed to evaluate the role of SGK1 played in immunoglobulin A (IgA) nephropathy.MethodsSeventy-six patients of biopsy-proven IgA nephropathy and 33 healthy volunteers were enrolled in this study. All patients and healthy volunteers' urinary and serum samples were tested for SGK1 expression by indirect enzyme-linked immunosorbent assay. Meanwhile all patients' renal tissues were semi-quantified for SGK1 expression by immunohistochemistry assay. The relationships between SGK1 expressions and clinical or pathological parameters were also assessed.ResultsSGK1 expression was upregulated in urine and renal tubules in patients of Oxford classification T1 and T2, whereas its expression in serum did not increase significantly. Relationship analysis indicated that urinary and tissue SGK1 expressions were associated with heavy proteinuria and renal insufficiency in patients with IgA nephropathy. On the other hand, RAS blockades would reduce the SGK1 levels both in urine and renal tissues.ConclusionThese results suggested that urinary SGK1 should be a good indicator of tubulointerstitial damage in patients of IgA nephropathy. SGK1 expressions in urine and renal tissues were associated with the activity of renin-angiotensin-aldosterone system.Summary at a Glance The present study demonstrates that one of a serine-threonine protein kinase, SGK1 levels in urine is associated with severe pathologic lesions in renal tissues, and subsequent renal insufficiency in IgAN.

Role of Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) in Immune and Inflammatory Diseases

Serum/glucocorticoid regulated kinase 1 (SGK1) in neurological disorders: pain or gain

SGK1 in Human Cancer: Emerging Roles and Mechanisms

SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease

Inhibition of Serum- and Glucocorticoid-Inducible Kinase 1 Enhances TLR-mediated Inflammation and Promotes Endotoxin-Driven Organ Failure

Urinary Serum- and Glucocorticoid-Inducible Kinase SGK1 Reflects Renal Injury in Patients with Immunoglobulin A Nephropathy

Research progress of SGK in respiratory system diseases

Inhibition of Serum- and Glucocorticoid-Regulated Protein Kinase-1 Aggravates Imiquimod-Induced Psoriatic Dermatitis and Enhances Proinflammatory Cytokine Expression through the NF-kB Pathway

SGK1 and Metabolic Syndrome

Emerging Role of Serum Glucocorticoid-Regulated Kinase 1 in Pathological Pain

Serum and Glucocorticoid Regulated Kinase 1 in Sodium Homeostasis

Serum and glucocorticoid-regulated kinase 1 (SGK1) as an emerging therapeutic target for cardiac diseases

Role of serum- and glucocorticoid-inducible kinase 1 in the regulation of hepatic gluconeogenesis.

SGK1 is regulated by metabolic-related factors in 3T3-L1 adipocytes and overexpressed in the adipose tissue of subjects with obesity and diabetes.

Serum and Glucocorticoid-Regulated Kinase 1 (SGK1) is a Predictor of Poor Prognosis in Non-Small Cell Lung Cancer, and Its Dynamic Pattern Following Treatment with SGK1 Inhibitor and Γ-Ray Irradiation Was Elucidated.

The role of serum/glucocorticoid-regulated kinase 1 in brain function following cerebral ischemia

SGK-1 Signalling Pathway is a Key Factor in Cell Survival in Ischemic Injury

SGK1 is Involved in Doxorubicin-Induced Chronic Cardiotoxicity and Dysfunction Through Activation of the NFκB Pathway

Hepatic serum- and glucocorticoid-regulated protein kinase 1 (SGK1) regulates insulin sensitivity in mice via extracellular-signal-regulated kinase 1/2 (ERK1/2).

Interaction Between Serum/Glucocorticoid-Regulated Kinase 1 and Interleukin-6 in Chronic Rhinosinusitis

Serum–Glucocorticoid Regulated Kinase 1 Regulates Macrophage Recruitment and Activation Contributing to Monocrotaline-Induced Pulmonary Arterial Hypertension